rs1060501145
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000335.5(SCN5A):c.5425G>T(p.Glu1809*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000335.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.5428G>T | p.Glu1810* | stop_gained | Exon 28 of 28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.5425G>T | p.Glu1809* | stop_gained | Exon 28 of 28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Truncating variants in SCN5A are known to be pathogenic (PMID: 20129283, 22789973). While this particular variant has not been reported in the literature, numerous pathogenic truncating variants have been reported downstream of this c.5428G>T variant in individuals affected with SCN5A-related conditions, suggesting that the C-terminal portion of the protein is clinically important (PMID: 14961552, 20129283, 24363796). This sequence change results in a premature translational stop signal in the last exon of the SCN5A mRNA at codon 1810 (p.Glu1810*). While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated SCN5A protein. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at